Robinson Bradshaw

Topic: General Electric

Make Room for Big Blue: IBM the Latest (and Largest) Entrant in the Race for the $1,000 Genome

The quest for the $1,000 genome—viewed by many as the point at which whole-genome sequencing will become cost-effective and widely available—is a fierce competition populated by a cast of start-ups and specialized genomics companies. The most well-known entrants in the next-generation sequencing market are companies such as Oxford Nanopore, Pacific Biosciences and Complete Genomics; names that […]